UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G
Under the Securities Exchange Act of 1934

(Name of Issuer) Cidara Therapeutics, Inc

(Title of Class of Securities) Common Stock

(CUSIP Number) 71757107

(Date of Event Which Requires Filing of this Statement) November 3, 2016

Check the appropriate box to designate the rule pursuant to which this
Schedule
is filed:
[ ]Rule 13d-1(b)
[ X ]Rule 13d-1(c)
[ ]Rule 13d-1(d)

      CUSIP No.                 71757107

          1.Names of Reporting Persons.

             Laurence W.Lytton

2. Check the Appropriate Box if a Member of a Group (See Instructions)

a)..........................................................................

(b)..........................................................................

      3.SEC Use Only

      4.Citizenship or Place of Organization

                USA

      5.Sole Voting Power       824,392

      6.Shared Voting Power     58,019

      7.Sole Dispositive Power  824,392

      8.Shared Dispositive Power 58,019


      9.Aggregate Amount Beneficially Owned by Each Reporting
      Person                    882,411


      10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions).................................


      11.Percent of Class Represented by Amount in Row (9)
                                5.3%


      12.Type of Reporting Person (See Instructions)

                        IN

            Item 1.

      (a)Name of Issuer         Cidara Therapeutics, Inc

      (b)Address of Issuer's Principal Executive Offices

                        6310 Nancy Ridge Drive
                        San Diego, CA 92121

              Item 2.

      (a)Name of Person Filing  Laurence W. Lytton

      (b)Address of Principal Business Office or, if none, Residence

                467 CPW
                New York, NY  10025

      (c)Citizenship                    USA

      (d)Title of Class of Securities   Common

      (e)CUSIP Number                   71757107

      Item 3.   not applicable


      Item 4.Ownership.

      (a)Amount beneficially owned: 882,411 shares consisting of
        781,867 shares held by the reporting person, 42,525 held in
        the AWL Family LLC, 6,256 held in the IKL Trust, 12,393 held
        in the KLL Family Trust, 27,300 held in the WWL Family Trust,
        and 12,070 shares held in other related accounts.

      (b)Percent of class:              5.3%

      (c)Number of shares as to which the person has:

      (i)Sole power to vote or to direct the vote       824,392.

      (ii)Shared power to vote or to direct the vote     58,019

      (iii)Sole power to dispose or to direct the disposition of  824,392.

      (iv)Shared power to dispose or to direct the disposition of  58,019


      Item 5.Ownership of Five Percent or Less of a Class:

                        Not applicable

      Item 6.Ownership of More than Five Percent on Behalf of Another Person.

                        Not applicable

      Item 7.Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding Company

                        Not applicable

      Item 8.Identification and Classification of Members of the Group

                        Not applicable

      Item 9.Notice of Dissolution of Group

                        Not applicable

      Item 10.Certification

      By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not held
for the purpose of or with the effect of changing or influencing the control
of the issuer of the securities and were not acquired and are not held
in connection with or as a participant in any transaction having that
purpose or effect.


SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.
      __11/11/16____________________________
      Date
      ____s/ Laurence W. Lytton____________________________
      Signature
      _____Laurence W. Lytton___________________________
      Name/Title

Cidara Therapeutics (NASDAQ:CDTX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Cidara Therapeutics Charts.
Cidara Therapeutics (NASDAQ:CDTX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Cidara Therapeutics Charts.